Evidence map›Paper›PMID 40460214›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Stool Processing Methods for Xpert Ultra Testing in Childhood Tuberculosis: A Prospective, Multicountry Accuracy Study.

Devan Jaganath, Pamela Nabeta, Mark P Nicol, Robert Castro, Peter Wambi, Heather J Zar, Lesley Workman, Rakesh Lodha, Urvashi B Singh, Ashish Bavdekar and 14 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Devan JaganathDivision of Pediatric Infectious Diseases, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-8555-5667
Pamela NabetaFIND, Geneva, Switzerland.
Mark P NicolMarshall Centre, School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Robert CastroCenter for Tuberculosis, University of California, San Francisco, San Francisco, California, USA.
Peter WambiWalimu, Kampala, Uganda.
Heather J ZarDepartment of Paedatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Lesley WorkmanDepartment of Paedatrics and Child Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-3433-6106
Rakesh LodhaDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Urvashi B SinghDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Ashish BavdekarDepartment of Pediatrics, KEM Hospital, Pune, India.
Sonali SanghaviDepartment of Microbiology, KEM Hospital, Pune, India.
André TrollipFIND, Geneva, Switzerland.
Aurélien MaceFIND, Geneva, Switzerland.
Maryline BonnetTransVIHMH, University of Montpellier, Institut de Recherche pour le Développement (IRD), Inserm, Montpellier, France.ORCID 0000-0002-1071-7393
Manon LounnasUniversity of Montpellier, IRD, CNRS, MIVEGEC, Montpellier, France.
Petra de HaasKNCV Tuberculosis Foundation, The Hague, The Netherlands.
Edine TiemersmaKNCV Tuberculosis Foundation, The Hague, The Netherlands.
David AllandDepartment of Medicine, Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Padmapriya BanadaDepartment of Medicine, Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0002-5217-6142
Adithya CattamanchiCenter for Tuberculosis, University of California, San Francisco, San Francisco, California, USA.
Morten RuhwaldFIND, Geneva, Switzerland.ORCID 0000-0002-1597-441X
Eric WobudeyaWalimu, Kampala, Uganda.ORCID 0000-0001-9574-5539
Claudia M DenkingerFIND, Geneva, Switzerland.
Stool H2H Study Team

Funding

Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in ChildrenK23HL153581 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANATH, DEVAN · 2020 to 2024
$946k
FINDNational Institute of Allergy and Infectious Diseases R01AI131617National Institute of Allergy and Infectious Diseases U01AI152087NHLBI NIH HHS K23 HL153581NHLBI NIH HHS K23HL153581NIH HHS
6 · The paper itself

Abstract

backgroundCentrifuge-free processing methods support stool Xpert Ultra testing for childhood tuberculosis, but data on their accuracy, acceptability, and usability are limited.

methodsWe conducted a prospective evaluation of stool Xpert Ultra in India, South Africa, and Uganda with 3 methods: the Stool Processing Kit (SPK), the Simple One-Step method (SOS), and the Optimized Sucrose Flotation method (OSF). Children <15 years old with presumptive tuberculosis underwent sputum testing with Xpert Ultra and culture. We compared the accuracy of each method against a microbiological reference standard (tuberculosis if Xpert Ultra or culture positive) and a composite reference standard (tuberculosis if confirmed or unconfirmed tuberculosis). We surveyed laboratory staff to assess the acceptability and usability of the methods.

resultsWe included 607 children, with a median age of 3.5 years (interquartile range, 1.3-7 years); 15.5% were human immunodeficiency virus positive. Against the microbiological reference standard, the sensitivities of SPK, SOS, and OSF were 36.9% (95% confidence interval, 28.6%-45.8%), 38.6% (17.2%-51.0%), and 31.3% (20.2%-44.1%), respectively, and the specificities, 98.2% (96.4%-99.3%), 97.3% (93.7%-99.1%), and 97.1% (93.3%-99%). The methods were acceptable and usable, but SOS was reported as most feasible to implement in a peripheral facility. Across methods, sensitivities increased among children who were culture positive (range, 55.0%-77.3%) and were low (13%-16.7%) against the composite reference standard. Adding stool Xpert Ultra increased sensitivity from 0% (OSF) to 11.8% (SPK/SOS), compared with sputum alone.

conclusionsStool processing methods for Xpert Ultra were acceptable and usable and performed similarly, with highest sensitivity among children with culture-positive tuberculosis.

Indexed as

FecesMolecular Diagnostic TechniquesSpecimen HandlingTuberculosisAdolescentChildChild, PreschoolFemaleHumansIndiaInfantMaleMycobacterium tuberculosisProspective StudiesSensitivity and SpecificitySouth AfricachilddiagnosticsstooltuberculosisXpert Ultra

Identifiers

PMID40460214
PMCPMC13017658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.